Sign in
CompletedNo phase

Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive Disorder

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
53 people enrolled
Started
15 Jul 2019
Ended
30 Sept 2024
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Continuous theta burst stimulation (cTBS)
  • shame rTMS
Record updated
25 May 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • age>18 years old
  • DSM-5 criteria for OCD
  • Y-BOCS total score > or = 16, despite treatment with an adequate trial of a serotonin reuptake inhibitor (SRI) and currently using adequate, stable dose of SRI at least 4 weeks. An adequate SRI trial is defined as treatment for at least 12 weeks on the SRI, that meets or exceeds the recommended dosage level for OCD
  • >or=9 yrs education

Who cannot take part

  • current use of any investigational drug
  • any additional current psychiatric comorbidity, except for obsessive-compulsive personality disorder
  • the inability to receive rTMS because of metallic implants, or history of seizures,or history of head injury, or history of neurosurgery
  • any major medical disease
  • history of long-time use of benzodiazepines
  • serious suicide risk
  • pregnancy or nursing of an infant
  • participation in current clinical study
  • TMS/DBS treatment at any point in their lifetime

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study will evaluate the possible therapeutic effects of repetitive transcranial magnetic stimulation(rTMS) in obsessive-compulsive disorder (OCD) in OCD patients who have not fully responded to pharmacotherapy, and the underlying neural mechanism by EEG.

The 4 groups in the trial

  • Group1: rTMS(bilateral SMA)Existing treatment, for comparison

    Continuous theta burst stimulation (cTBS) stimulation will be applied over the bilateral SMA once a day, 5 days/week, for 4 weeks.

    Treatment: Continuous theta burst stimulation (cTBS)

  • Group2: rTMS(right DLPFC)Treatment being tested

    Continuous theta burst stimulation (cTBS) stimulation will be applied over the right DLPFC once a day, 5 days/week, for 4 weeks.

    Treatment: Continuous theta burst stimulation (cTBS)

  • Group3: rTMS(right DLPFC+bilateral SMA)Treatment being tested

    Continuous theta burst stimulation (cTBS) stimulation will be applied over the right DLPFC and bilateral SMA once a day, 5 days/week, for 4 weeks.

    Treatment: Continuous theta burst stimulation (cTBS)

  • Group4: shame rTMSSham treatment, for comparison

    The sham rTMS will be applied over the bilateral SMA once a day, 5 days/week, for 4 weeks.

    Treatment: shame rTMS

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
A Randomized Clinical Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Obsessive-Compulsive Disorder
Record updated
25 May 2025